MYLK

MYLK Full Name

myosin light chain kinase

MYLK Introduction

MYLK encodes myosin light chain kinase, a calcium/calmodulin-dependent serine/threonine kinase that is critical for smooth muscle contraction. The human gene is situated on chromosome 3q21.1, spanning over 280 kilobases with more than 30 exons. Alternative promoter usage and splicing generate multiple tissue-specific isoforms, including the long non-muscle form (telokin) and the smooth-muscle-specific variant. This complex genomic architecture allows precise spatial and temporal regulation of kinase activity across different cell types. Single nucleotide polymorphisms in this region have been linked to various vascular phenotypes, highlighting its relevance in both basic physiology and translational medicine.The MYLK protein contains several conserved functional modules: an N-terminal actin-binding domain, a central catalytic core with typical kinase motifs, and a C-terminal regulatory segment that includes calmodulin-binding and autoinhibitory sequences. Alternative splicing produces at least five major isoforms that differ in their molecular weight (from 130 to 220 kDa) and subcellular localization. The longest isoform is predominantly expressed in visceral and vascular smooth muscle, while shorter variants appear in endothelial cells and circulating leukocytes. This structural plasticity enables MYLK to interact with distinct binding partners, modulating not only contractility but also cytoskeletal remodeling, cell migration, and barrier integrity in a context-dependent manner.

Figure 1.Mechanism of MYLK.

Biochemical Mechanism of Action
Upon elevation of intracellular calcium, calmodulin binds to MYLK's regulatory domain, relieving autoinhibition and enabling ATP-dependent phosphorylation of the regulatory light chain (RLC) of myosin II at serine 19. This phosphorylation event increases myosin ATPase activity, promoting cross-bridge cycling between actin and myosin filaments and generating force development. The kinase's activity is finely tuned by additional phosphorylation sites targeted by protein kinase A and protein kinase C, which can either enhance or suppress its catalytic efficiency. Moreover, MYLK exhibits non-kinase functions, including scaffolding roles that organize signalosomes near the cytoskeleton, thereby coupling mechanical stimuli to transcriptional responses and metabolic adaptations in stressed cells.

Physiological Roles Beyond Contraction
Although best known for governing smooth muscle tone in airways, blood vessels, and gastrointestinal tract, MYLK also participates in non-muscle processes such as endothelial junction dynamics, platelet aggregation, and fibroblast chemotaxis. During inflammation, MYLK-mediated phosphorylation of RLC facilitates endothelial cell contraction, increasing paracellular permeability and promoting leukocyte extravasation. In developing embryos, the kinase contributes to neural tube closure and cardiac morphogenesis. Additionally, telokin—a short MYLK-derived peptide—acts as an independent stabilizer of unphosphorylated myosin filaments, providing a reserve pool for rapid contractile responses. This functional pleiotropy positions MYLK as a central node integrating calcium signals with diverse cellular outputs across multiple organ systems.

Alternate Names for MYLK

MYLK; myosin light chain kinase; KRP; AAT7; MLCK; MLCK1; MYLK1; smMLCK; MLCK108; MLCK210; MSTP083; myosin light chain kinase, smooth muscle; telokin; kinase-related protein; myosin, light polypeptide kinase; smooth muscle myosin light chain kinase;